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ABSTRACT  7 
Resveratrol exhibits many health benefits however, low water-solubility and instability to 8 
processing conditions such as heating can be some of the main challenges for its processing and 9 
formulation. Here the complexation of -lactoglobulin (-Lg) with resveratrol was investigated to 10 
improve its solubility and stability. The solubility of resveratrol in water was determined as 11 
7mg/100ml. Resveratrol--Lg  nanoparticles (181.8 nm) were produced at pH 6 and 75°C for 45 12 
min. Heating resveratrol solutions at 75°C for 45 min resulted in isomerization of resveratrol and 13 
reduced antioxidant activity. However, resveratrol--Lg nanocomplexes which had undergone the 14 
same heat treatment exhibited improved antioxidant activity. Heating at pasteurisation conditions 15 
led to similar results and both native -Lg and nanoparticles exhibited a protective effect against 16 
heat induced chemical changes in resveratrol resulting in enhanced antioxidant activity. 17 
 2 
Fluorescence measurements revealed strong interactions of resveratrol with both, native protein 18 
and nanoparticles. 19 
Keywords: Resveratrol; -lactoglobulin; nanoparticles; antioxidant activity; heating 20 
 21 
1. Introduction 22 
Nowadays, consumers are attracted to dietary supplements instead of drugs to improve health. 23 
and oOral administration is the most convenient and commonly applied method to develop new 24 
nutraceuticals. Based on many studies, the predominant problem of nutraceuticals is poor 25 
bioavailability due to their low aqueous solubility which, affects over 40% of the new chemical 26 
entities produced by high throughput screening processes (Lipinski, 2002). Several reasons 27 
contribute to the solubility problem: 1) high molecular weight; 2) high Log of the octanol-water 28 
partition coefficient (log P), which is a measure of a drug's lipophilicity. In order to improve the 29 
aqueous solubility, numerous researchers have developed many approaches such as particle size 30 
reduction, crystal engineering, salt formation, solid dispersion and surfactant complexation 31 
(Savjani, Gajjar., & Savjani, 2012). New techniques like nanoparticles, nanotubes, 32 
nanosuspensions and nanocomplexes are employed to improve the solubility of poorly soluble 33 
drugs and nutraceuticals (Rabinow, 2004; Tran, Tran, & Lee, 2013). Proteins like zein, whey 34 
proteins, soy proteins and other natural polymers like cyclodextrins have been applied not only in 35 
pharmaceutical but also in food applications (Duarte et al., 2015; Gorji et al., 2015; Pujara, 36 
Jambhrunkar, Wong, McGuckin, & Popat, 2017). Simple and safe carrier candidates, which meet 37 
the GRAS (Generally Recognised As Safe) qualification and possibly have essential health 38 
benefits, should be investigated to improve aqueous solubility and stability of bioactives.   39 
 40 
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Resveratrol (3,5,4'-Trihydroxystilbene), is a typical non-flavonoid phenol that belongs to the 41 
stilbene family and has various properties including antioxidant, anti-cancer, anti-inflammatory, 42 
and antineoplastic (Bhat & Pezzuto, 2002; Jang et al., 1997; Soleas, Diamandis, & Goldberg, 43 
1997). Resveratrol is thought to be one of the main contributors to the famous “French paradox”: 44 
despite the French people’s high-fat intake, a low cardiovascular diseases incidence was found. It 45 
has been ascribed partly to the red wine consumption (Catalgol, Batirel, Taga, & Ozer, 2012). 46 
Since then, the studies of resveratrol have been carried out broadly in the food and pharmacy field. 47 
There are 72 different natural resources which contain resveratrol, especially grapes, peanuts and 48 
blueberries (Burns, Yokota, Ashihara, Lean, & Crozier, 2002; Jimenez-Garcia et al., 2012; Lyons 49 
et al., 2003). Even though resveratrol is widely distributed in various plants and fruits, there are 50 
some pharmacokinetic limitations which lead to its low bioavailability: The low water solubility, 51 
labile properties, and rapid metabolism (Amri, Chaumeil, Sfar, & Charrueau, 2012; Pund, Joshi, 52 
& Patravale, 2016). The low solubility of resveratrol in oral administration is due to the chemical 53 
structure of resveratrol: two phenolic rings bonded together by a double styrene bond which leads 54 
to two isometric forms ,cis- and trans-resveratrol (Gambini et al., 2015). It is believed that the 55 
trans-isomeric form is more abundant than cis-resveratrol, while the trans-isomer is able to 56 
transform into cis-isomer under light exposure and heating. Light exposure allows a rapid 57 
isomerization of trans-resveratrol, especially in the ultraviolet radiation at 366nm or at low 58 
concentration (Flieger, Tatarczak-Michalewska, & Blicharska, 2017; Gambini et al., 2015). 59 
Heating not only leads to increased solubility but also results in degradation, isomerization and 60 
reduction of antioxidant activity. The effect of heating on resveratrol can be complex depending 61 
on temperature (Flieger et al., 2017; Lee et al., 2014). In order to overcome its low solubility and 62 
low stability, encapsulation might be a solution. The encapsulation of resveratrol with a number 63 
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of biopolymers has been investigated including chitosan and γ-poly (Jeon, Lee, & Lee, 2016), soy 64 
protein isolate (Pujara et al., 2017), milk protein (Gorji et al., 2015), zein (Penalva et al., 2015) 65 
and β-lactoglobulin (Zhang, Liu, Subirade, Zhou, & Liang, 2014). The main whey protein, β-66 
lactoglobulin, plays an interesting role in transporting retinol molecules and binds small 67 
hydrophobic molecules. Resveratrol has been found to bind to the surface of the hydrophobic 68 
pocket of β-lactoglobulin (Liang & Subirade, 2010; Liang, Tajmir-Riahi, & Subirade, 2008). Thus, 69 
β-lactoglobulin can be an attractive candidate as a carrier to offer a solution to both, poor solubility 70 
and low stability to processing /storage conditions such as heating and light exposure. 71 
In previous work of our group, β-lactoglobulin nanoparticles were found to complex with 72 
caffeine (Guo, Harris, Kaur, Pastrana, & Jauregi, 2017). Higher binding affinity of  73 
β-lactoglobulin in nanoparticles form rather than in the native form was found. The aim of the 74 
present work was to apply this method to produce resveratrol-β-lactoglobulin nanoparticles and 75 
investigate the effect of these nanoparticles and native β-lactoglobulin on the solubility and 76 
stability of resveratrol under different thermal processing conditions. The main hypothesis tested 77 
here was that complexation of protein (native and/or nanoparticles) with resveratrol in aqueous 78 
solution can improve its solubility and/or stability. The stability was measured in terms of 79 
antioxidant activity. In addition, fluorescence measurements were carried out to gain an insight 80 
into the interactions between these two molecules.  81 
 82 
 83 
 84 
 85 
 86 
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2. Materials and methods  87 
2.1. Material 88 
Trans-resveratrol (98% w/w) was supplied by Evolva RES140332 . The β-Lactoglobulin from 89 
bovine milk ≥85.0 % (PAGE), lyophilized powder L2506 was purchased from Sigma. 90 
Folin-Ciocalteu reagents: Folin-Ciocalteu (F9252), and Sodium carbonate BioXtra,≥99.0% 91 
(S7795) were purchased from Sigma. 92 
Reagents of ABTS method: 2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium 93 
salt (ABTS) ≥98.0 % (HPLC) (A1888), Potassium persulfate (K2S2O8) ACS reagent, ≥99.0% 94 
(21622, (±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox), 97%  (238813),  95 
and ethanol, ≥99.8% (GC) (32221) were purchased from Sigma-Aldrich  96 
Reagents of the ferric reducing antioxidant power (FRAP)  method reagents： 97 
TPTZ (2,4,6-Tris(2-pyridyl)-s-triazine) (T1253)；Ferric Chloride Hexahydrate(207926) were 98 
purchased from Sigma-Aldrich. 99 
 100 
2.2  Determination of resveratrol solubility in water solution  101 
A series of resveratrol solutions/suspensions were prepared from 1mg/100ml, 3mg/100ml, 102 
5mg/100ml, 7mg/100ml, 8mg/100ml, and 9ml/100ml to determine the solubility of resveratrol. 103 
All the solutions/suspensions were covered by tissue paper and were stirring with a magnetic stirrer 104 
at room temperature for 2 hours before any measurements. Two methods were applied to determine 105 
resveratrol solubility in water solution: the direct spectrophotometric method and total phenolic 106 
content by Folin-Ciocalteu method. 107 
The direct spectrophotometric method: The λmax value of resveratrol aqueous solution 108 
(2mg/100ml) was determined by using a Lambda 20 spectrophotometer (Perkin-Elmer®) and 109 
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scanning UV absorption from wavelength 190nm to 600nm with 1 nm spectral bandwidth. The 110 
absorbance of resveratrol solutions/suspensions was measured at the maximum wavelength by the 111 
Spectrophotometers (Ultrospec ® 1100 pro) using a quartz cuvette with a path length of 1cm and 112 
deionized water was used as the blank. The solubility of resveratrol at room temperature was 113 
determined from the plot of the absorbance against concentration as the concentration after which 114 
no further significant increases were observed.  115 
Folin-Ciocalteu method: The total phenolic content of all concentrations of resveratrol 116 
solutions/suspensions were measured by Folin- Ciocalteu method at 760nm. In brief, 0.2 ml of 117 
resveratrol solution was added to around 6.0ml of deionized water into a 10ml volumetric flask. 118 
Folin-Ciocalteu reagent (0.5ml) was added and mixed. After 1 minute and no longer than 8 119 
minutes, 1.5 ml 20% sodium carbonate solution was added and the volume adjusted to 10ml. After 120 
2 hours incubation in the dark, the absorbance was recorded at 760nm using a UV-Vis 121 
Spectrophotometer (Ultrospec ® 1100 pro). Deionised water was used as the blank. All the 122 
experiments were carried out in triplicates, and the results were expressed in gallic acid equivalents 123 
(GAE; mg/L) using a gallic acid (10-120mg/L) standard curve. The solubility of resveratrol was 124 
determined as the concentration at which the GAE value reached a peak and remained constant 125 
afterwards.  126 
2.3 Production of resveratrol-β-lactoglobulin nanoparticles 127 
Native β-lactoglobulin powder (0.01 g) was added into 5ml resveratrol standard solutions 128 
/suspensions of varying concentrations in a 7ml Sterile container. Then the pH of the sample was 129 
adjusted to 6.0 using a pH meter (Mettler Toledo, Switzerland) with 0.1M HCl and 0.1M NaOH. 130 
After this, the sample was introduced into a water bath (Grant Instrument Ltd., Cambridge, United 131 
Kingdom) that have been previously heated at 75 °C. The sample was kept for 45 minutes at this 132 
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temperature; it must be noted that the temperature of the sample reached the set temperature after 133 
about 13 minutes. On completion of the incubation time, samples were transferred to an ice bath 134 
for 10 minutes to terminate incubation. After 10 minutes in the ice bath, the pH of the sample was 135 
measured. The particle size was determined by dynamic light scattering (DLS). 136 
2.4 The effect of heating and native β-lactoglobulin and β-lactoglobulin nanoparticle on 137 
the stability of resveratrol 138 
After determination of solubility of resveratrol, all the following studies were carried out in a 139 
range of concentrations of resveratrol at the solubility or below. A set of resveratrol aqueous 140 
solutions in the range of solubility were used as a control and compared against samples of the 141 
same concentration of resveratrol that underwent different treatments. There were three different 142 
treatments: heating (see details below), the addition of native β-lactoglobulin (details below) and 143 
β-lactoglobulin nanoparticles (see section 2.3). 144 
When studying the effect of heating, each of the resveratrol solutions/suspensions were heated 145 
at 75°C in a water-bath for 45 minutes and moved to an ice bath for 10 minutes afterwards. Then, 146 
samples were taken for analysis. This temperature was chosen as this was the temperature at which 147 
the nanoparticles were formed. 148 
 149 
When exploring the effect of adding native β-lactoglobulin, 0.01g native β-lactoglobulin powder 150 
was added to 5ml resveratrol standard solutions/suspensions of varying concentrations in a 7ml 151 
Sterile container. Then samples were subjected to heat treatment.   152 
The effect of heating, adding native β-lactoglobulin and β-lactoglobulin nanoparticles on the 153 
stability of resveratrol were determined by total phenolic content and the total antioxidant activity. 154 
For the total phenolic content, the Folin-Ciocalteu method mentioned above was applied, and when 155 
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measuring the samples with native β-Lactoglobulin and β-Lactoglobulin nanoparticles, the 156 
interference of protein was eliminated by substracting the GAE value of protein from the GAE 157 
value of samples. All the samples were prepared and determined in duplicate. 158 
For the total antioxidant activity, the [2,2’-Azinobis(3-Ethylbenzothiazoline-6-Sulphonic Acid)] 159 
(ABTS) Free Radical Scavenging Activity Assay and Ferric ion Reducing Antioxidant Power 160 
assay (FRAP) were used which are described in detail below. 161 
ABTS method: The total antioxidant activity of all samples was measured by ABTS assay at 162 
734nm, which was modified from Re et al. (1999). In general, the ABTS•+ stock solution was 163 
prepared by mixing solution 5ml ABTS solution (7mM, 50ml volume, stored in an amber flask 164 
and kept under refrigeration at 0-4°C up to one month) and 88μl Potassium Persulfate (K2S2O8) 165 
solution (140mM, 10ml volume, stored in an amber flask and dark place at room temperature up 166 
to one month) together. Then the mixture was kept in the dark and room temperature for at least 167 
16h prior to use. For the study of phenolic compounds, the working solution of the ABTS•+ was 168 
obtained by diluting the ABTS•+ stock solution with phosphate buffered saline (PBS pH 7.4) to an 169 
absorbance of 0.70±0.02 at 734nm. 20μl of samples was added into 2ml ABTS•+ working solution, 170 
and the mixture was homogenised by 1mins vortex. The mixture was then incubated in the dark 171 
for 6 minutes, and the absorbance (ABSsample) was recorded at 734nm using a UV-Vis 172 
Spectrophotometers (Ultrospec ® 1100 pro). The absorbance of ABTS•+ working solution was 173 
measured at the same wavelength and used as control (ABScontrol). The PBS was to blank the 174 
spectrophotometer. The percentage of scavenging activity of each sample on ABTS•+ was 175 
calculated as the inhibition% (I%) using the following equation (Shah & Modi, 2015): Eq.(1) 176 
𝐈% =
(𝐀𝐁𝐒𝐜𝐨𝐧𝐭𝐫𝐨𝐥− 𝐀𝐁𝐒𝐬𝐚𝐦𝐩𝐥𝐞)
𝐀𝐁𝐒𝐜𝐨𝐧𝐭𝐫𝐨𝐥
× 𝟏𝟎                                                                                              (1) 177 
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When measuring the samples with native β-Lactoglobulin and β-Lactoglobulin nanoparticles, 178 
the interference of protein was eliminated by subtracting the I% of protein from the I% of samples. 179 
All the samples were prepared and determined in duplicate. 180 
FRAP method: The total antioxidant activity of all samples was also assessed by FRAP method 181 
at 595nm, which was modified from Benzie and Strain (1996). In principle, The stock solution of 182 
FRAP method included: 300 mM Acetate buffer (pH 3.6, 2.699 g sodium acetate trihydrate and 183 
16ml (16.8g) glacial acetic acid dissolved in 1L deionised water), 2,4,6-tripyridyl-s-triazine 184 
(TPTZ) (10mM) in 10ml HCl (40mM), and 20mM Ferric Chloride Hexahydrate aqueous solution. 185 
The FRAP reagent was mixed with the 25ml Acetate buffer, 2.5ml TPTZ and 2.5ml Ferric chloride 186 
solutions. Then, 10 μl of the sample/standard was added into 300μl FRAP  reagent in a 187 
microcentrifuge tube and vortexed for 10 seconds. Then 100μl of this mixture, in triplicates, was 188 
transferred into the microwell plate (96well, NUNC, FB) and absorbance was measured at 595nm 189 
by a computer controlled Tecan Microplate reader. Results were express as the ascorbic acid 190 
equivalents (AAE) using an ascorbic acid (0.001761mg/ml-0.1761mg/ml) standard curve. 191 
Increased absorbance of the reaction mixture indicated greater reduction capability. When 192 
measuring the samples with native β-Lactoglobulin and β-Lactoglobulin nanoparticles, the 193 
interference of protein was eliminated by subtracting the AAE value of protein from the AAE 194 
value of samples. All the samples were prepared and determined in triplicate. 195 
 196 
2.5  The effect of native β-lactoglobulin and β-lactoglobulin nanoparticle on resveratrol 197 
under pasteurisation conditions 198 
Different concentrations of resveratrol standard solutions/suspensions, resveratrol-native β-199 
lactoglobulin solutions and resveratrol-β-lactoglobulin nanoparticles solutions prepared using the 200 
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methods above were incubated at pasteurisation conditions, 63°C for 30 minutes. Then the total 201 
phenolic content was determined by Folin-Ciocalteu method. The total antioxidant capacity of 202 
samples was measured by the ABTS method. All the samples were determined in duplicate. 203 
2.6  Fluorescence measurement of resveratrol-β-lactoglobulin solutions 204 
The concentrations of resveratrol solutions were 0.23mg/100ml, 0.46mg/100ml, 0.92mg/100ml, 205 
1.84mg/100ml, and 2.48mg/100ml. The protein concentration of resveratrol-native β-Lg solutions 206 
and resveratrol-β-Lg nanoparticles solutions was kept constant at 0.2% w/v. According to Liang, 207 
L., & Subirade, M. (2012), the protein intrinsic fluorescence due to tryptophan (Trp) and tyrosine 208 
(Tyr) residues is sensitive to the fluorophore environment and thus potentially an indicator of 209 
changes in protein conformation. Trp in the protein emits fluorescence when excited at a 210 
wavelength (λex) of 295 nm. The protein conformational changes as a result of interactions with 211 
the quencher can be studied by the changes of the intensity of emission. Therefore, the degree of 212 
β-Lg conformational changes was determined based on fluorescence emission of tryptophan (Trp), 213 
which was measured by fluorescence spectrophotometer with the temperature controller (Varian 214 
Cary Eclipse, United Kingdom). Fluorescence spectra were obtained after excitation at 295nm, 215 
scanning an emission wavelength range between 300 nm to 510 nm, using 5nm excitation and 216 
emission slits wavelength. The data was collected by Cary Eclipse software version 2 (Varian Cary 217 
Eclipse, United Kingdom) and samples were analysed at a constant temperature of 20°C. 218 
According to Liang and Subirade (2012), the fractional residual fluorescence or relative 219 
fluorescence intensity (RFI=Fmax/F0×100) was the fraction of the total protein fluorescence that 220 
was not quenched, and thus the fraction of β-Lg not bound to the ligand; where, F0 is fluorescence 221 
intensity of pure β-Lg; Fmax is the intensity at the emission maximum (λmax). A low ratio of RIF 222 
demonstrated a strong binding of the ligand, while a ratio of 100% indicated no binding. 223 
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For the calculation of binding constant and binding number, the fluorescence quenching data 224 
were analysed by fitting to the Stern-Volmer equation (Liang et al., 2008) in dynamic quenching. 225 
Eq. (2):  226 
𝐅𝟎/𝐅𝐦𝐚𝐱 = 𝟏 + 𝐊𝐪 × 𝛕𝟎 × [𝐑𝐞𝐬𝐯𝐞𝐫𝐚𝐭𝐫𝐨𝐥] = 𝟏 + 𝐊 × [𝐫𝐞𝐬𝐯𝐞𝐫𝐚𝐭𝐫𝐨𝐥]                                               (2) 227 
F0 and Fmax are the fluorescence emission intensities without and with resveratrol; [resveratrol] 228 
is resveratrol concentration; Kq (M-1s-1) is the fluorescence quenching rate constant; τ0 (s) is the 229 
fluorophore fluorescence lifetime without quencher, and K (Kq xτ0) is defined as the Stern-230 
Volmer quenching constant. By plotting  Fo/Fmax as a function of [resveratrol] and according to 231 
Eq. (2) K was obtained from the slope of the straight line.  232 
For the static quenching, the binding constant Ks and binding number n can be calculated 233 
according to the double logarithmic equation  (He et al., 2016)  Eq. (3): 234 
 𝐥𝐨𝐠[(𝐅𝟎 − 𝐅𝐦𝐚𝐱)/𝐅𝐦𝐚𝐱)] = 𝐥𝐨𝐠𝐊𝑺 + 𝐧 𝐥𝐨𝐠[𝐫𝐞𝐬𝐯𝐞𝐫𝐚𝐭𝐫𝐨𝐥]                                                          (3)                      235 
 236 
From a plot of log (Fo-Fmax/Fo) as a function of  log [resveratrol] and according to Eq. 3 the Ks 237 
value was obtained from the intercept of the resulting straight line and n from the slope. 238 
 239 
2.7 The stability of resveratrol to light  240 
Resveratrol solutions/suspensions were exposed to overhead light (Philips, TL-D 840, 70w, and 241 
distant was 1 meter) in the laboratory during 0, 1, 3, 6 and 12 hours. The total phenolic content 242 
was measured at 303nm by a spectrophotometer (Ultrospec® 1100 pro) and the Folin-Ciocalteu 243 
method as described above. The total antioxidant capacity of samples was measured by ABTS as 244 
described above. All the samples were determined in duplicate. 245 
2.8. Statistical analysis 246 
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Figures were plotted using MS Excel, MS Office 2013 (Microsoft Corporation, Redmond, WA, 247 
USA). The results were statistically analysed by analysis of variance using IBM® SPSS® 248 
Statistics version 20.0. Means and standard deviations from at least two measurements carried out 249 
on two samples repeated. The significance level was set at 0.05. Data fitting of experimental data 250 
to models was performed with Excel MS Office 2013 (Microsoft Corporation, Redmond, WA, 251 
USA)  252 
3. Results and discussion  253 
3.1. The solubility of resveratrol in aqueous solutions   254 
The solubility of resveratrol in water was determined by measuring total phenolic content using 255 
the direct spectrophotometric method and Folin-Ciocalteu method (Fig S1). 256 
In the direct spectrophotometric method, the max of 2mg/100ml resveratrol aqueous solution was 257 
determined as 303 nm. Therefore, solubility was measured by measuring absorbance of a range of 258 
concentrations at this wavelength . The absorbance of resveratrol reached a peak and levelled off 259 
at resveratrol concentration 7mg/100ml after an approximately linear increase. Results from Folin-260 
Ciocalteu method showed the same trend, and at 7mg/100ml the GAE also remained constant at 261 
about 35.5 mg/L. Both these results indicated that 7mg/100ml corresponded to the limit of 262 
solubility of resveratrol in water. Surprisingly, it was in disagreement with the reported solubility 263 
value (3mg/100ml), but this was determined by high-performance liquid chromatography (HPLC) 264 
(Jeon et al., 2016; Pujara et al., 2017). Moreover, the solubility value reported by Camont et al. 265 
(2009) using the UV spectrophotometric method was 6.85 mg/100ml, but they claimed that this 266 
increased solubility was due to sonication which helped to dissolve resveratrol. Another possible 267 
explanation of this different result was that, in our method, samples were not filtered prior to 268 
absorbance measurements, so any insoluble particles of resveratrol in suspension could have led 269 
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to an overestimation of the solubility. However, in the Folin assay, 0.5ml samples were taken and 270 
20 times dilution was applied so any interferences by suspended particles would be minimal. In 271 
any case filtration was not an option in this study as filtration of aqueous solutions of resveratrol 272 
with a 0.45 μm Polyethersulfone (PES) membrane proved to be very difficult and all resveratrol 273 
was retained (results obtained by HPLC but not shown here). Only the 0.22 m Polypropylene 274 
(PVDF) filters showed high permeability for resveratrol but still, a reduction in absorbance 275 
(7.69%) was observed. Moreover, with this filter high retention of β-Lg nanoparticles (about 80%) 276 
was obtained and that also resulted in retention of resveratrol. Therefore,  as filtration is a key step 277 
before injecting the samples into the column, HPLC was not used in this study to determine the 278 
concentration of resveratrol.   279 
To sum up, in this study, the solubility of resveratrol in deionized water at room temperature 280 
was 7mg/100 ml. As our solubility result was higher than some of the reported values, it was 281 
assumed that at 7mg/100 ml, a nearly saturated solution of resveratrol was obtained. Therefore, 282 
the rest of experiments were carried out at the range of 1mg/100ml to 7mg/100ml. 283 
 284 
3.2 The effect of light on resveratrol solubility and stability  285 
For the stability to light, the resveratrol suspensions were exposed to the lab light for 12 hours. 286 
Based on the measurement of the direct spectrophotometric method, the concentration of 287 
resveratrol had an increasing trend with one exception at 1mg/100ml (Fig 1). Also, according to 288 
Figure 1, there was a reduction of GAE value at 1mg/100ml, but no significant difference at 289 
3mg/100ml-7mg/100ml during 12 hours light exposure with a wide variance. Corresponding to 290 
the total phenolic content, inhibition% had the same increasing trend at 3mg/100ml-7mg/100ml. 291 
A significant positive correlation between total phenolic content (the direct spectrophotometric 292 
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method) and total antioxidant capacity was observed as Pearson value was 0.844. Therefore, it was 293 
concluded that the resveratrol solution was not stable when exposed to lab light. Simimalrly, 294 
Pinelo, Rubilar, Sineiro, and Núñez (2005) found that resveratrol solution achieved maximum 295 
antioxidant activity at 22°C in water bath after three days.  296 
Also, according to Orgován, Gonda, and Noszál (2017), the trans-resveratrol is more lipophilic 297 
than its isomer. Moreover, they also found that the cis-resveratrol has over ten times more 298 
solubility than trans-resveratrol. Another potential explanation could be that at high concentration, 299 
the trans-resveratrol converted to cis-resveratrol under the light condition and more cis-resveratrol 300 
dissolved in the solution leading to an increase in antioxidant activity. 301 
302 
 303 
 15 
 304 
Figure 1: the stability of resveratrol to light by total phenolic content at 303nm (A), total phenolic 305 
content by Folin-Ciocalteu method (B) and total antioxidant capacity by ABTS (C). ■0h ■1h ■ 306 
3h ■6h ■12h.  307 
3.3. The characterization of resveratrol-β-lactoglobulin nanoparticles 308 
After heating the mixture of resveratrol and β-lactoglobulin (0.2%w/v) to form nanoparticles, 309 
the size of nanoparticles was measured by dynamic light scattering. The average size of 310 
resveratrol-ß-lactoglobulin nanoparticle was 181.80 nm±1.48 nm with polydispersion index 0.048. 311 
The nanoparticle size was close to that reported by Fonseca, Khalil, and Mainardes (2017)  who 312 
encapsulated resveratrol with bovine serum albumin nanoparticles (175nm) by desolvation method 313 
with ethanol. There was no significant difference in size among different concentrations of 314 
resveratrol nanoparticles and nanoparticles alone. So the nanoparticles (200nm) produced were not 315 
affected by the concentrations of resveratrol. On the other hand, the size of nanoparticles was 316 
smaller than the nanoparticles we produced in our previous work (Guo et al 2017) and this is 317 
possibly because  no  hydration step (at 4 °C overnight) was applied prior to the production of 318 
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nanoparticles. Here no hydration step was applied in order to reduce any risk of resveratrol 319 
degradation during storage.  320 
 321 
3.4. Effect of heating, native β-lactoglobulin, and resveratrol-β-lactoglobulin nanoparticles 322 
on the stability of resveratrol  323 
The effect of heating was investigated under the same conditions as those used in the β-324 
lactoglobulin nanoparticles preparation: heating at 75°C for 45 mins. After heating, 10 minutes in 325 
the ice bath allowed rapid reduction of samples temperature to room temperature. The 326 
concentration of native β-lactoglobulin added to the resveratrol solution was the same as that used 327 
in the preparation of nanoparticles. The stability of resveratrol solutions was assessed after: (i) 328 
heating, (ii) protein addition and (iii) nanoparticles production; this was assessed by comparing 329 
the total phenolic content (Folin-Ciocalteu method), and total antioxidant activity (ABTS method 330 
and the FRAP method) of treated samples with those of the control (resveratrol aqueous solution 331 
1mg/100ml-7mg/100ml).   332 
3.4.1. Total phenolic content by Folin-Ciocalteu method 333 
A clear increment of GAE value was observed after heating at all concentrations (Fig 2), 334 
indicating that the heating has a significant influence on resveratrol. Even though heating could 335 
improve the solubility of resveratrol in water dramatically (Filipa et al., 2003) since in this study 336 
all samples were subjected to an ice bath after heating, the increase of solubility due to heating 337 
would have been reduced or eliminated. So the increase in GAE observed at all concentrations, 338 
particularly those below the solubility (< 7 mg/100 ml) could be due to chemical changes in the 339 
molecule which resulted in changes in its oxidative status and/or oxidation power and led to 340 
enhanced blue colour production. However, at 7 mg/ 100 ml, the big increase in GAE from 30.01 341 
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to 81.46 mg/L may also be partly due to an increase in solubility since near saturation might have 342 
been reached at this concentration of resveratrol. Flieger et al. (2017) pointed out that when the 343 
temperature reached 75°C or above, heating could induce the isomerization of resveratrol from 344 
trans-resveratrol to cis-resveratrol even without light. Also, Orgován et al. (2017) found that the 345 
solubility of cis-resveratrol was over ten times more than that of trans-resveratrol in water as trans-346 
resveratrol was more lipophilic than its isomer. Thus, a possible explanation for the increase in 347 
GAE observed here could be that some of the trans-resveratrol isomerized to cis-resveratrol and 348 
that led to an increase in solubility. 349 
When adding native β-lactoglobulin, an increase in total phenolic content happened although 350 
this increase was not significant (P>0.05) compared with the control sample at all concentrations. 351 
The interference of protein on total phenolic content measurement has been eliminated by 352 
subtracting the GAE value corresponding to the protein to the total GAE value (see Methods in 353 
2.3). So it can be assumed that any increases in GAE as a result of protein addition were due to 354 
interactions between native β-lactoglobulin and resveratrol.  355 
Moreover, the samples of resveratrol with β-lactoglobulin nanoparticles had the largest 356 
increment in phenolic content among these three treatments, and it was around three times the 357 
phenolic content of the control sample at all concentrations (Fig 2). Interestingly the nanoparticles 358 
(combined effect of heat and protein addition) led to a much higher increase than the heating alone 359 
for those concentrations of RSV below solubility whereas for the highest concentration it had 360 
almost the same effect than heating alone. 361 
Overall these results suggest that at concentrations below saturation heating enhanced 362 
resveratrol and ß-lactoglobulin interactions as well as inducing isomerisation thus, these combined 363 
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effects led to an increase in total phenol content. For the highest resveratrol concentration which 364 
was about saturation point heating had the strongest effect and led to a further increase in solubility.  365 
 366 
 367 
Figure 2: The total phenolic content results by Folin-Ciocalteu method of: ■ resveratrol aqueous 368 
solution (control); ■heated resveratrol; ■  resveratrol with native β-Lg; ■ resveratrol with 369 
nanoparticles of β-Lg. Results were expressed as Gallic Acid Equivalents GAE mg/L. 370 
3.4.2. Total antioxidant activity by ABTS and FRAP methods 371 
Besides total phenolic content, the total antioxidant capacity of resveratrol was measured to 372 
assess changes as a result of the different treatments and in this way assess the stability of 373 
resveratrol. In this work, two methods were applied to measure antioxidant capacity: ABTS 374 
method and FRAP method. Results in Fig 3.demonstrated a reduction in antioxidant activity 375 
(inhibition %) after heating at all concentrations (P<0.05). According to Mikulski, Gorniak, and 376 
Molski (2010), trans-resveratrol was a stronger antioxidant than cis-isomer due to the planar 377 
conformation; this conformation would ensure the main parameters contributing to antioxidant 378 
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activity: favourable spin and unpaired electron distribution. Therefore, this reduction in antioxidant 379 
activity supports further the hypothesis that trans-resveratrol changed to cis-isomer during heating 380 
with the subsequent reduction in antioxidant activity and increase in total phenols (as shown in Fig 381 
2).  382 
The addition of native β-lactoglobulin led to no significant changes in antioxidant activity when 383 
compared against the control samples, indicating that the antioxidant activity would not be masked 384 
by ß-lactoglobulin. 385 
On the other hand, the resveratrol-β-lactoglobulin nanoparticles had higher activity than heated 386 
samples (P<0.05) at 1-5 mg/100ml. So the reduction in activity due to heating was counteracted 387 
by the interactions of resveratrol with the nanoparticles which led to similar or higher activity than 388 
the control. This suggests a protective effect of β-lactoglobulin nanoparticles against heat-induced 389 
loss of antioxidant activity; possibly the interactions of β-Lg nanoparticles with resveratrol hinder 390 
its isomerisation. Interestingly, at 7mg/100ml, the difference in antioxidant activity between the 391 
heated sample (14.52%) and resveratrol-β-lactoglobulin nanoparticle samples (21.31%) was not 392 
statistically significant (p=0.072). At 7 mg/100 ml, the heating led to two counteracting effects: 393 
(1) improving solubility which would increase activity and (2) isomerization which would result 394 
in reduced activity, this is why both the heating effect and the nanoparticles did not have a 395 
significant impact on antioxidant activity at this concentration 396 
 397 
 20 
 398 
Figure 3: The total antioxidant activity results by ABTS method of: ■resveratrol aqueous solution 399 
(control); ■heated resveratrol; ■ resveratrol with nativeβ-Lg ■ resveratrol with nanoparticles of 400 
β-Lg. Results were expressed as inhibition% (I%) 401 
Another antioxidant activity measuring method, FRAP, was also applied to study the effects of 402 
different treatments on resveratrol. The antioxidant activity results by FRAP method expressed as 403 
AAE (mg/ml) are shown in Fig 4. It was noted that there was no significant difference (P<0.05) in 404 
activity between 5mg/100ml and 7mg/100ml of control samples, which might suggest that 405 
solubility of resveratrol in water was 5mg/100ml instead of 7 mg/100ml. 406 
A reduction in activity due to heating was observed for samples up to 5mg/100ml in agreement 407 
with ABTS measurements (Fig 3). Surprisingly, a sharp increase was observed at 7mg/100ml. This 408 
observation agrees with the sharp increase measured in total phenolic content at this concentration 409 
(Fig 2).  Therefore, the increase in antioxidant activity at 7mg/100 ml could be explained by an 410 
increase in solubilized resveratrol in the form of cis-resveratrol as a result of heating.  411 
 412 
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 413 
Figure 4: The total antioxidant activity results by FRAP method of: ■ resveratrol aqueous solution 414 
(control); ■ heated resveratrol; ■ resveratrol with native β-Lg; ■ resveratrol with nanoparticles 415 
of β-Lg. Results were expressed as Ascorbic Acid Equivalents (AAE mg/ml) 416 
In agreement with ABTS results the resveratrol-β-lactoglobulin nanoparticles had the highest AAE 417 
value at all concentrations among all treatments (except heated sample at 7mg/100ml), whilst 418 
resveratrol with native ß-lactoglobulin samples had the same antioxidant activity as the control 419 
samples (P>0.05) (Fig 4). So these results again confirm a protective effect of β-lactoglobulin 420 
nanoparticles against heat-induced loss of antioxidant activity. Moreover, according to the FRAP 421 
method, there was a significant effect of β-Lg nanoparticles as compared to native β-Lg (Fig 4). 422 
To conclude, the results of both antioxidant capacity methods indicated that β-lactoglobulin 423 
nanoparticles had the ability to prevent chemical changes in resveratrol during heating and in this 424 
way protect its antioxidant capacity.  425 
 426 
  427 
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3.5. The effect of pasteurization on stability of resveratrol with and without protein  428 
In order to study further the protective effect of β-lactoglobulin against thermal degradation of 429 
resveratrol an industrial thermal process, pasteurisation, was applied to resveratrol with and 430 
without protein. Pasteurisation is a common commercial method to minimise health hazards from 431 
food pathogens and to extend shelf life for liquid food and drinks. Thus, it is important to examine 432 
the effect of pasteurisation on resveratrol stability and how would adding protein affect this.  433 
Firstly, as shown in Fig 5A, the total phenolic content of resveratrol after pasteurisation showed 434 
the same results as the heating at 75°C: dramatic increase of GAE value after pasteurisation. 435 
Secondly, it demonstrated that pasteurising resveratrol with native β-lactoglobulin had no 436 
significant effect in total phenolic content at all concentrations as compared to control. However, 437 
pasteurization of resveratrol with nanoparticles showed a significant decrease in total phenolic 438 
content. A possible reason could be that the interaction with β-lactoglobulin suppressed the 439 
isomerization undergone by resveratrol at 63°C  This would agree with the observations above. 440 
On the other hand, the antioxidant activity (%inhibition) of standard resveratrol slightly reduced 441 
after pasteurisation at 1mg/100ml and 3mg/100ml but increased at 5mg/100ml and 7mg/100ml 442 
(Fig 5B). These results were different to results of heating at 75°C, which indicated that heating at 443 
75 °C led to more degradation than at 63°C, and here samples were not put in an ice bath after 444 
pasteurisation so heating might have led to increased solubility. 445 
 446 
Moreover by comparing the pasteursised samples with and without protein it is clear that the 447 
presence of protein led to higher antioxidant activity. The increment of total antioxidant activity 448 
after pasteurisation in the samples containing protein could be explained as above, ie: the 449 
 23 
interactions between resveratrol and protein hindered the isomerisation of resveratrol that led to 450 
reduced activity.  451 
 452 
 453 
 454 
Figure 5: The total phenolic content (A) and the total antioxidant activity (B) of : 455 
■ resveratrol aqueous solution (control); ■ resveratrol with native β-Lg; ■resveratrol with β-Lg 456 
nanoparticles. The plane colour bars were samples before pasteurisation and the patterned bars the 457 
same sample after pasteurisation.  458 
 459 
To conclude, adding protein particularly in the nano form would suppress the heating effect on 460 
resveratrol. Pasteurisation led to a small decrease in AOC at all concentrations (except at the 461 
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highest) whilst resveratrol samples with protein (both in native and nanoparticle form) showed an 462 
increase in AOC. 463 
 464 
  3.6. Determination of β-lactoglobulin-resveratrol interactions by fluorescence 465 
Fluorescence measurements were carried out in order to obtain a further insight into the 466 
resveratrol-protein interactions. The fluorescence measurements of resveratrol-β-lactoglobulin 467 
solutions were conducted at constant protein concentration (for both native and nanoparticles) with 468 
varying concentration of resveratrol from 0.23mg/100ml-2.5mg/100ml.  469 
 470 
 471 
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Figure 6: The fluorescence emission spectra of (A) resveratrol-native β-lg at 0mg/100ml-472 
2.48mg/100ml resveratrol (1-6); (B) resveratrol-β-lg nanoparticle at 0mg/100ml-2.48mg/100ml 473 
resveratrol (1-6). 474 
Fig 6 (A) showed the intrinsic fluorescence emission spectra of native β-Lg in presence of 475 
different concentrations of resveratrol. As resveratrol concentration increased, a reduction in 476 
intensity of fluorescence emission was observed. This was an indication of partial disruption of 477 
the protein structure which led to a change in the polarity of the fluorophore (Trp groups in the 478 
protein) and hence the reduced intensity. There was also a slight shift in λmax to longer wavelengths 479 
(from 337.0 nm to 357.14 nm) which is in agreement with the protein conformational changes 480 
induced by the resveratrol as reported by Liang et al. (2008). Interestingly the changes in 481 
fluorescence intensity at increased resveratrol concentrations were not as big for the β-Lg 482 
nanoparticles (Fig 6B) as for the native protein. The RFI value of native β-Lg (22.82%) was higher 483 
than the RFI value of β-Lg nanoparticles (46.65%) indicating stronger interactions between these 484 
two molecules when β-Lg is in native than in nanoparticle form. The nanoparticles were formed 485 
by heat denaturation of protein; as the protein conformation had been already altered the addition 486 
of resveratrol did not lead to important changes in fluorescence intensity. However, the λmax shift 487 
was much bigger for the nanoparticles than for the native protein (from 335.08nm to 377.89nm) 488 
suggesting a big change in the fluorophore environment towards a more hydrophilic environment. 489 
This could be explained by hydrophobic interactions between the resveratrol and the unfolded 490 
protein molecule which would lead to further exposure of the fluorophore to a more hydrophilic 491 
media. Therefore, there was a large effect on the protein tertiary structure. Overall this seems to 492 
agree with the stronger effect observed on the stability of resveratrol by the nanoparticles than the 493 
native protein.  494 
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Furthermore, from the linear plot of  Fmax/Fo as a function of resveratrol concentration and 495 
according to to Eq (2) the Stern-Volmer equation constant K of Resveratrol with native β-Lg was 496 
3.18×104 M-1 (R2= 0.986). Assuming that τ0 was 1.28 ns for Trp of β-Lg (EricDufour, Genot, & 497 
Haertlé, 1994; Stojadinovic et al., 2013) the Kq was determined as 2.5×10
13 M-1s-1, which was 498 
higher than the maximal dynamic quenching constant (1-2.0×1010 M-1s-1)  . This  suggests that 499 
binding of resveratrol with β-Lg followed a static quenching mechanism where the fluorophore 500 
formed a stable complex with another molecule that was non-fluorescent. This result was in 501 
agreement with that reported by Liang and Subirade (2012) and Liang et al. (2008), who 502 
confirmed that β-Lg fluorescence quenching induced by resveratrol is a static quenching. Thus, 503 
from the linear equation of log (F0-Fmax)/Fmax  as a function of log [resveratrol] (R2=0.985 ) 504 
and according to Eq. 3  the binding constant Ks was determined from the intercept of the slope as 505 
1.67×105 M-1 and from the slope the binding number, n  was obtained as  1.33. This means 1.33 506 
resveratrol molecules bind one β-Lg molecule and also Ks was in the range of 105 and 106 M-1, 507 
which was in agreement with binding constants reported for native β-Lg and a range of 508 
substrates such as folic acid with Ks= 4.3× 105 M-1 (Liang & Subirade, 2010) and EGCG with 509 
Ks=1.05×105M-1 (Shpigelman, Israeli, & Livney, 2010). However, the Stern-Volmer quenching 510 
equation might not be suitable to apply to the resveratrol-β-Lg nanoparticles binding since the β-511 
Lg fluorescence emission maximum changed with  resveratrol concentration.  512 
Overall from our work, it was demonstrated that more quenching by resveratrol occurred when 513 
binding β-lactoglobulin in the native than in nanoparticle form. Resveratrol bound native β-Lg 514 
following the Stern-Volmer static quenching model at ratio 1: 1 in agreement with previously 515 
reported by Liang et al. (2008); most probably resveratrol bound at the surface of the protein. On 516 
the other hand, the heat denaturation undergone by the protein during the formation of the 517 
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nanoparticles exposed new binding sites to which resveratrol bound. The quenching was not as 518 
strong as with native β-Lg but these type of interactions (most probably of hydrophobic nature) 519 
led to further structural changes in the protein as shown by the shift to longer wavelengths. This 520 
may also explain the protective effect of nanoparticles against chemical changes in resveratrol 521 
upon heating and the increased antioxidant activity.  522 
Denaturation of the protein affects the binding of different ligands in different ways. For 523 
example, Liang and Subirade (2012) found that thermal denaturation of β-Lg reduced the binding 524 
affinity for tocopherol whilst it increased for resveratrol. Moreover, Shpigelman et al. (2010) 525 
reported a higher association of heated β-Lg with Epigallocatechin-3-gallate (EGCG) than native 526 
β-Lg whilst Perez, Andermatten, Rubiolo, and Santiago (2014) demonstrated no significant 527 
differences between native and heat-induced β-Lg aggregates binding to linoleic acid. Protein 528 
denaturation leads to structural changes which then can change access to binding sites in the 529 
protein; polarity and size of the ligands influences which binding sites their bind to. 530 
 531 
4. Conclusions  532 
In this work, the solubility of resveratrol in water was determined as 7mg/100ml by the direct 533 
spectrophotometric method and Folin-Ciocalteu method. Resveratrol was not stable to light, and 534 
light exposure resulted in higher phenolic content and total antioxidant capacity. Nanoparticles of 535 
β-lactoglobulin were produced in the presence of resveratrol with average size around 181.8nm 536 
and the concentration of resveratrol had no significant difference in the size of nanoparticles. The 537 
heat induced isomerisation of resveratrol at 75°C led to increased solubility but reduced 538 
antioxidant capacity. β-lactoglobulin nanoparticles showed a protective effect against heat induced 539 
loss of antioxidant activity. Moreover, when  resveratrol with and without protein was treated at 540 
 28 
pasteurisation conditions both, native and β-lactoglobulin nanoparticles showed a protective effect 541 
against heat induced loss of activity and an increase in antioxidant activity. Fluorescence 542 
measurements of resveratrol binding to native -Lg showed strong fluorescence quenching of -543 
Lg by resveratrol suggesting strong interactions between these two molecules. Interactions with -544 
Lg nanoparticles led to smaller quenching but a significant shift of max to longer wavelengths 545 
which suggested also strong interactions with resveratrol. Overall it was found that the interactions 546 
of protein and resveratrol in combination with heating led to improved antioxidant capacity. Thus, 547 
complexation of protein with resveratrol proved to have a stabilization effect.  These findings are 548 
very relevant for the optimum processing and formulation of resveratrol. 549 
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